文献速递新发突发、热带与寄生虫病

登革病毒1、3、4型人类感染模型的免疫转录组特征比较分析

A comparative analysis of the immunotranscriptomic features of DENV-1, -3, and -4 human challenge models.
PubMed 文献 · J Infect Dis · 2026-06-27

该研究比较了登革病毒1、3、4型人类感染模型(DHIM)的转录组与临床特征,发现高峰RNA血症日存在跨血清型保守的上调核心抗病毒反应;部分DHIM-3参与者出现与高RNA血症和症状相关的胞质翻译下调独特基因特征;体外PBMC实验显示保守与独特基因表达特征随病毒剂量而非血清型变化。

要点

  • 高峰RNA血症日存在跨血清型保守上调的核心抗病毒基因反应。
  • 部分DHIM-3参与者出现胞质翻译下调特征,与高RNA血症和症状相关。
  • 体外PBMC中基因表达特征随病毒剂量而非血清型变化。

核心结论

  • 实验性登革病毒感染后病毒载量与转录反应及临床症状相关。

研究设计与样本

  • 比较分析DHIM-1、DHIM-3和DHIM-4研究,并将原代人PBMC体外暴露于不同滴度的DENV-1或DENV-3进行bulk RNA测序。

主要发现

  • 跨DHIMs鉴定出高峰RNA血症日一组保守上调基因,代表独立于血清型的核心抗病毒反应。
  • 部分DHIM-3参与者出现提示胞质翻译下调的独特基因特征,伴RNA血症和症状升高。
  • 体外PBMC暴露于DENV显示保守和独特基因表达特征随病毒剂量而非血清型变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dengue virus (DENV) infections cause a range of clinical symptoms, from a mild febrile illness to severe disease. Higher levels of DENV RNAemia are associated with severe dengue, although this relationship is incompletely understood. Dengue Human Infection Models (DHIMs), in which volunteers are experimentally infected with underattenuated DENV strains, provide an invaluable tool for studying early virologic, transcriptional, and immunologic features of infection. DHIM studies using DENV-1, DENV-3, and DENV-4 have demonstrated qualitatively distinct clinical features, however, the contribution of RNAemia and serotype to divergent transcriptional and clinical profiles in these challenge models remains unclear. METHODS: In this work, we performed a comparative analysis of DHIM-1, DHIM-3, and DHIM-4 studies to determine shared and unique features of the transcriptional response to infection and their associations with RNAemia and clinical symptoms. We then exposed primary human PBMC in vitro to DENV-1 or DENV-3 at varying titers and performed bulk RNA sequencing. RESULTS: Across DHIMs, we identified a set of conserved, upregulated genes at day of peak RNAemia, representing a core antiviral response independent of serotype. Further, a unique gene signature indicating downregulated cytoplasmic translation emerged in a subset of DHIM-3 participants with elevated RNAemia and symptomatology. In vitro PBMC exposure to DENV demonstrated that conserved and unique gene expression signatures varied as a function of viral dose rather than serotype. CONCLUSIONS: These data show that viral burden correlates with transcriptional responses and clinical symptomatology following experimental DENV infection, contributing to our understanding of dengue pathogenesis and immunity.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hardy CSC, Ware LA, Friberg H, et al. A comparative analysis of the immunotranscriptomic features of DENV-1, -3, and -4 human challenge models. J Infect Dis. 2026. PMID: 42362196. doi:10.1093/infdis/jiag338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。